martes, 8 de septiembre de 2020

Blueprint Medicines' genetically targeted lung cancer drug approved

Blueprint Medicines' genetically targeted lung cancer drug approved

The Readout

Damian Garde & Meghana Keshavan

More reads

  • Blueprint Medicines wins U.S. approval for genetically targeted lung cancer drug. (STAT)
  • China’s I-Mab gets boost from AbbVie to develop new cancer immunotherapy. (STAT) 
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)